CBL International Limited Audited Results for the Year Ended December 31, 2022 27-04-2023, 14:51

Introducing Citeline’s Sitetrove Diversity Module, Combining Robust Clinical Investigator and Site Intelligence With Patient Demographics to Support the Diversification of Clinical Trials 23-05-2023, 20:01

Nogin Announces Jonathan Huberman as Chairman and Chief 28-01-2023, 05:22